Osteosarcoma medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
Current standard treatment is to use [[neoadjuvant]] [[chemotherapy]] ([[chemotherapy]] given before [[surgery]]) followed by surgical resection. The percentage of tumor cell [[necrosis]] (cell death) seen in the tumor after surgery gives an idea of the prognosis and also lets the oncologist know if the [[chemotherapy]] regimen should be altered after surgery. | |||
Standard therapy is a combination of limb-salvage [[orthopedic surgery]] and a combination of high dose [[methotrexate]] with [[leucovorin]] rescue, intra-arterial [[cisplatin]] [[caffeine]], [[adriamycin]], [[ifosfamide]] with [[mesna]], BCD, [[etoposide]], muramyl tri-peptite (MTP). | Standard therapy is a combination of limb-salvage [[orthopedic surgery]] and a combination of high dose [[methotrexate]] with [[leucovorin]] rescue, intra-arterial [[cisplatin]] [[caffeine]], [[adriamycin]], [[ifosfamide]] with [[mesna]], BCD, [[etoposide]], muramyl tri-peptite (MTP). | ||
Line 17: | Line 10: | ||
Ifosfamide can be used as an adjuvant treatment if the [[necrosis]] rate is low. | Ifosfamide can be used as an adjuvant treatment if the [[necrosis]] rate is low. | ||
3-year event free survival ranges from 50% to 75% | 3-year event free survival ranges from 50% to 75% and 5-year survival ranges from 60% to 85% in some studies. Osteosarcoma has one of the lowest survival rates for pediatric cancer despite chemotherapy's success in osteosarcoma of 6 chemotherapies, [[interferon-alpha]], [[interleukin-2]], and being the prototype of solid tumors in cancer. | ||
60% to 85 | |||
Osteosarcoma has one of the lowest survival rates for pediatric cancer despite chemotherapy's success in osteosarcoma of 6 chemotherapies, [[interferon-alpha]], [[interleukin-2]], and being the prototype | |||
of solid tumors in cancer | |||
Fluids are given for hydration. | Fluids are given for hydration. |
Revision as of 17:34, 23 September 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Osteosarcoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Osteosarcoma medical therapy On the Web |
American Roentgen Ray Society Images of Osteosarcoma medical therapy |
Risk calculators and risk factors for Osteosarcoma medical therapy |
Overview
Medical Therapy
Current standard treatment is to use neoadjuvant chemotherapy (chemotherapy given before surgery) followed by surgical resection. The percentage of tumor cell necrosis (cell death) seen in the tumor after surgery gives an idea of the prognosis and also lets the oncologist know if the chemotherapy regimen should be altered after surgery.
Standard therapy is a combination of limb-salvage orthopedic surgery and a combination of high dose methotrexate with leucovorin rescue, intra-arterial cisplatin caffeine, adriamycin, ifosfamide with mesna, BCD, etoposide, muramyl tri-peptite (MTP).
Ifosfamide can be used as an adjuvant treatment if the necrosis rate is low.
3-year event free survival ranges from 50% to 75% and 5-year survival ranges from 60% to 85% in some studies. Osteosarcoma has one of the lowest survival rates for pediatric cancer despite chemotherapy's success in osteosarcoma of 6 chemotherapies, interferon-alpha, interleukin-2, and being the prototype of solid tumors in cancer.
Fluids are given for hydration.
Drugs like Kytril and Zofran help with nausea and vomiting.
Neupogen, epogen, Neulasta help with white blood cell counts and neutrophil counts.
Blood helps with anemia.
Samarium
- Samarium is a radioactive drug that targets areas where bone cells growing, such as tumor cells in bone.
- It helps relieve pain caused by cancer in the bone and it also kills bloodcells in bone marrow.
- Treatment with samarium may be followed by stem cell transplant.
- Before treatment with samarium, stem cells (immature blood cells) are removed from the blood or bonemarrow of the patient and are frozen and stored. After treatment with samarium is complete, the stored stem cells are thawed and given back to the patient through an infusion. These re-infused stem cells grow into (and restore) the body's blood cells.